Big pharma won’t stop raising prices in 2017 — it’ll just do it smarter By: MarketWatch December 21, 2016 at 08:46 AM EST To avoid being the next Mylan, companies will keep raising prices — but do it smarter. Read More >> Related Stocks: AbbVie Allergan Plc Bristol-Myers Squibb CVS Health Corp Eli Lilly Express Scripts Holding Gilead Sciences Mylan Novo Nordisk A/S ADR Pfizer Sanofi-Aventis S.A. ADR UnitedHealth Group Valeant Pharmaceuticals International, Inc.